Hugh Davis for Contract Pharma

Check out Frontage's CBO, Hugh Davis, PhD, interview with Contract Pharma about Frontage's range of services and its expansion into biologics and early development capabilities.

"*" indicates required fields

First Name*

Last Name*

Company*

State*

Country

Email*

Phone*

Please only hit the submit button once.

I AGREE*

By submitting this form I agree that Frontage may process my data in the manner described in Frontage’s Privacy Policy.

Name

This field is for validation purposes and should be left unchanged.

Hugh Davis for Contract Pharma

Resources to Consider

Gene Therapy Podcast with Hugh Davis

Validation of a 384 gene hybridization capture-based pharmacogenomics...

Testing of Carryover & After MRD Benchtop Stability for...

Sequencing Assays for Biomarker Discovery and Pharmacodynamics in...

Rapid, accurate and highly customizable assay platforms for...

Microbiological Testing Considerations for Pharmaceutical Products

Companion Diagnostics for Alzheimer’s Disease

Development of Stable Nanoemulsion Formulation as an Ophthalmic Drug...

Development and validation of an LC-MS/MS method for the...

A Competitive Ligand-binding Assay for the Detection of Neutralizing...

Immunoassays for Drug Discovery

Utilizing Ligand Binding Assays (LBA) and Critical Reagents for Drug...